CLAVUCO 625

Here is the Product Information Manual for Clavuco 625 Tablets:

Product Information Manual

Brand Name:
Clavuco 625 Tablets

Composition:
Each film-coated tablet contains:

• Amoxycillin – 500 mg
• Clavulanic Acid (as Potassium Clavulanate) – 125 mg

Pack Size:
10 tablets per strip

Shelf Life:
1.5 years from the date of manufacture

Product Description:
Clavuco 625 Tablet is a combination antibiotic formulation containing Amoxycillin, a broad-spectrum penicillin, and Clavulanic Acid, a beta-lactamase inhibitor. It is effective in treating bacterial infections that are resistant to standard penicillin therapy.

Indications:

• Upper and lower respiratory tract infections
• Sinusitis and otitis media
• Skin and soft tissue infections
• Urinary tract infections
• Dental infections
• Bone and joint infections

Dosage and Administration:
To be taken as prescribed by the physician. Usually administered every 8 or 12 hours, depending on infection severity. Preferably taken at the start of a meal to improve absorption and minimize gastrointestinal discomfort.

Mechanism of Action:

• Amoxycillin disrupts bacterial cell wall synthesis, leading to cell lysis.
• Clavulanic Acid inhibits beta-lactamase enzymes produced by resistant bacteria, thereby restoring Amoxycillin’s effectiveness.

Storage Instructions:
Store below 25°C in a dry place, protected from light and moisture. Keep out of reach of children.

Contraindications:

• Hypersensitivity to penicillins, cephalosporins, or any component of the formulation
• History of liver dysfunction associated with similar antibiotic combinations

Precautions:

• Use with caution in patients with hepatic or renal impairment
• Monitor liver function during prolonged therapy
• Not recommended in pregnancy and lactation unless clearly indicated

Possible Side Effects:

• Nausea, vomiting, or diarrhea
• Rash or allergic skin reactions
• Headache or dizziness
• Rare: Liver enzyme elevations, cholestatic jaundice

Discontinue use and consult a healthcare provider if signs of allergy (e.g., rash, swelling, difficulty breathing) or severe side effects occur.

Marketed by:
Adduco Pharmaceuticals Pvt Ltd
Address: GK-1/284, Gyan Khand – 1, Indirapuram, Ghaziabad, Uttar Pradesh, India, 201014
Email: info@adducopharma.com
Contact: 000000000

Note:
Prescription drug. For use only under the supervision of a registered medical practitioner.